Future Developments in Esophageal Cancer Research

被引：3

作者：

Ajani, Jaffer A. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA

来源：

GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2009年 / 38卷 / 01期

关键词：

Esophageal cancer; Combine modality therapy; Biomarkers; Individualization of therapy; Epidemiology; POSITRON-EMISSION-TOMOGRAPHY; RECEIVING RADIATION-THERAPY; EARLY METABOLIC-RESPONSE; PREOPERATIVE CHEMORADIOTHERAPY; 1996-1999; PATTERNS; NATIONAL PRACTICE; CARCINOMA; SURGERY; CHEMORADIATION; ADENOCARCINOMA;

D O I：

10.1016/j.gtc.2009.01.001

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

The progress that has been made against esophageal carcinoma is limited. Many relevant issues remain. Herein the author discusses his outlook for the treatment of this disease, which has a steadily rising incidence.

引用

页码：183 / +

页数：7

共 40 条

[1]

For localized Gastroesophageal cancer, you give chemoradiation before surgery, but then what happens? [J].

Ajani, Jaffer A. ;

Correa, Arlene M. ;

Swisher, Stephen G. ;

Wu, Tsung-Teh .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) :4315-4316

[2]

[Anonymous], CANC STAT

[3]

Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I).: A comparison of two phase II trials with long-term follow-up [J].

Bader, Franz G. ;

Lordick, Florian ;

Fink, Ulrich ;

Becker, Karen ;

Hoefler, Heinz ;

Busch, Raymonde ;

Siewert, Joerg R. ;

Ott, Katja .

ONKOLOGIE, 2008, 31 (07) :366-372

[4]

Prospective study of cyclin D1 overexpression in Barrett's esophagus: Association with increased risk of adenocarcinoma [J].

Bani-Hani, K ;

Martin, IG ;

Hardie, LJ ;

Mapstone, N ;

Briggs, JA ;

Forman, D ;

Wild, CP .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1316-1321

[5]

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival [J].

Berger, AC ;

Farma, J ;

Scott, WJ ;

Freedman, G ;

Weiner, L ;

Cheng, JD ;

Wang, H ;

Goldberg, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4330-4337

[6]

Oncogenic pathway signatures in human cancers as a guide to targeted therapies [J].

Bild, AH ;

Yao, G ;

Chang, JT ;

Wang, QL ;

Potti, A ;

Chasse, D ;

Joshi, MB ;

Harpole, D ;

Lancaster, JM ;

Berchuck, A ;

Olson, JA ;

Marks, JR ;

Dressman, HK ;

West, M ;

Nevins, JR .

NATURE, 2006, 439 (7074) :353-357

[7]

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus [J].

Bosset, JF ;

Gignoux, M ;

Triboulet, JP ;

Tiret, E ;

Mantion, G ;

Elias, D ;

Lozach, P ;

Ollier, JC ;

Pavy, JJ ;

Mercier, M ;

Sahmoud, T .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) :161-167

[8]

Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age [J].

Brown, Linda Morris ;

Devesa, Susan S. ;

Chow, Wong-Ho .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16) :1184-1187

[9]

BROWN LM, 1995, J NATL CANCER I, V87, P104, DOI 10.1093/jnci/87.2.104

[10]

Detection of interval distant metastases - Clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy [J].

Bruzzi, John F. ;

Swisher, Stephen G. ;

Truong, Mylene T. ;

Munden, Reginald F. ;

Hofstetter, Wayne L. ;

Macapinlac, Homer A. ;

Correa, Arlene M. ;

Mawlawi, Osama ;

Ajani, Jaffer A. ;

Komaki, Ritsuko R. ;

Fukami, Norio ;

Erasmus, Jeremy J. .

CANCER, 2007, 109 (01) :125-134

← 1 2 3 4 →